Antiviral Activity of CRISPR/Cas9 Ribonucleoprotein Complexes on a Hepatitis B Virus Model In Vivo-Reference-Cited by-同舟云学术

Antiviral Activity of CRISPR/Cas9 Ribonucleoprotein Complexes on a Hepatitis B Virus Model In Vivo

Published:2022-12 Issue:6 Volume:56 Page:816-822
ISSN:0026-8933
Container-title:Molecular Biology
language:en
Short-container-title:Mol Biol

Author:

Kostyusheva A. P.,Brezgin S. A.,Ponomareva N. I.,Goptar I. A.,Nikiforova A. V.,Gegechkori V. I.,Poluektova V. B.,Turkadze K. A.,Sudina A. E.,Chulanov V. P.,Kostyushev D. S.

Publisher

Pleiades Publishing Ltd

Subject

Structural Biology,Biophysics

Link

https://link.springer.com/content/pdf/10.1134/S0026893322060097.pdf

Reference22 articles.

1. World Health Organization. 2017. Global Hepatitis Report, 2017.

2. Chulanov V.P., Zueva A.P., Kostyushev D.S., Brezgin S.A., Volchkova E.V., Maleyev V.V. 2017. Hepatitis C can be cured: will hepatitis B become next? Ter. Arkh. 89, 4–13.

3. Ko C., Chakraborty A., Chou W.-M., Hasreiter J., Wettengel J.M., Stadler D., Bester R., Asen T., Zhang K., Wisskirchen K. 2018. Hepatitis B virus (HBV) genome recycling and de novo secondary infection events maintain stable cccDNA levels. J. Hepatol. 69 (6), 1231–1241. https://doi.org/10.1016/j.jhep.2018.08.012

4. Seeger C., Sohn J.A. 2016. Complete spectrum of CRISPR/Cas9-induced mutations on HBV cccDNA. Mol. Ther. 24, 1258–1266. https://doi.org/10.1038/mt.2016.94

5. Seeger C., Sohn J.A. 2014. Targeting hepatitis B virus with CRISPR/Cas9. Mol. Ther. Nucl. Acids. 3, e216. https://doi.org/10.1038/mtna.2014.68

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tackling hepatitis B Virus with CRISPR/Cas9: advances, challenges, and delivery strategies;Virus Genes;2024-08-28

2. Stochastic Packaging of Cas Proteins into Exosomes;Molecular Biology;2024-02

3. Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA;Viruses;2023-11-25